Germline Variants in Highly Selected Patients With Prostate Cancer-In Reply
JAMA Oncol
.
2019 Sep 1;5(9):1369.
doi: 10.1001/jamaoncol.2019.2120.
Authors
Oliver Sartor
1
,
Piper Nicolosi
2
,
Robert L Nussbaum
2
Affiliations
1
Tulane University School of Medicine, New Orleans, Louisiana.
2
Invitae Corporation, San Francisco, California.
PMID:
31294747
DOI:
10.1001/jamaoncol.2019.2120
No abstract available